BOFAS Abstracts Archive

You can search for abstracts by using the search bar below.
Alternatively you can browse through podium and poster presentations by selecting the year and / or type below. You can further refine your search using tags or use the search bar.

 



Categories: Abstracts, 2025-Nov, Podium

Is Elevated HBA1C Associated with Post-Operative Complications in Midfoot Charcot Reconstruction? Myth Or Reality?

Andrew Isaac Christudoss, Bhargava Krishna Balineni, Madhu Tiruveedhula

Basildon University Hospital, Basildon

Introduction: Guidance from the Royal College of Anaesthetists suggests that patients with poorly controlled diabetes are at increased risk of peri-operative complications, wound related issues, and prolonged hospital stays. Nevertheless, surgery remains recommended in urgent and semi-urgent cases. This study aimed to compare post-operative outcomes in patients undergoing Midfoot Charcot reconstruction, stratified by pre-operative HbA1c levels.

Method: Following local governance approval, we retrospectively reviewed patients who underwent midfoot Charcot reconstruction between January 2018 and December 2024. Patients were grouped based on pre-operative HbA1c: Group A (<69 mmol/mol) and Group B (≥69 mmol/mol). Procedures included urgent first-stage debridement, elective second-stage reconstruction or single-stage reconstruction. All patients were treated using standardised protocols involving deep tissue sampling, local antibiotic-eluting agents (Cerament G), and a short course of systemic antibiotics. Post-operative complications and outcomes were compared.

Results: A total of 105 patients were analysed: 82 in Group A and 23 in Group B. Both groups were similar in age and BMI. The median HbA1c was 50.5 mmol/mol in Group A (range: 30–69) and 79 mmol/mol in Group B (range: 70–129). Post-operative complications occurred in 11 patients (13.4%) in Group A and 3 patients (13%) in Group B. Infections occurred in five patients in Group A, with three requiring returns to theatre. In Group B, three patients developed wound infections, but none required re-operation. One patient in Group A required major amputation; none in Group B did. Fourteen patients died during follow-up (10 in Group A, 3 in Group B), all beyond 30 days post-operatively and the cause was unrelated to surgery.

Conclusion: There was no significant difference in post-operative morbidity, mortality, or complication rates between the groups. Elevated HbA1c should not be viewed as a contraindication to surgery in patients with complex diabetic foot pathology.

Previous Article Is bone allograft the right choice for tibio-talo-calcaneal fusions using the hindfoot nailing system? Nottingham Hospitals' Experience
Next Article Is Internal Brace Augmentation (IBA) better than isolated Modified Brostrom Gould (MBG) repair for chronic lateral ligament injury: a retrospective analysis
Print


Click thumbnail below to view poster / thumbnail:

Archive of Abstracts

2025   -   Prize Winners  |  All Abstracts   (Nov)
2025   -   Prize Winners  |  All Abstracts   (Jan)
2024   -   Prize Winners  |  All Abstracts
2023   -   Prize Winners  |  All Abstracts
2022   -   Prize Winners  |  All Abstracts
2021   -   Prize Winners  
2019   -   Podium  |  Poster
2018   -   Podium  |  Poster
2017   -   Podium  |  Poster
2016   -   Podium  |  Poster
2015   -   Podium  |  Poster
2014   -   Podium  |  Poster
2013   -   Podium  |  Poster
2011   -   All Abstracts
2009   -   All Abstracts
2008   -   All Abstracts
2007   -   All Abstracts
2006   -   All Abstracts
2005   -   All Abstracts
2004   -   All Abstracts
2002   -   All Abstracts
2001   -   All Abstracts
2000   -   All Abstracts
1999   -   All Abstracts
1998   -   All Abstracts
1997   -   All Abstracts
1996   -   All Abstracts
1995   -   All Abstracts
1994   -   All Abstracts
1993   -   All Abstracts
1991   -   All Abstracts
1990   -   All Abstracts
1989   -   All Abstracts
1987   -   All Abstracts
1985   -   All Abstracts
1983   -   All Abstracts